-
Momentum Grants program awards funding for bold brain research
https://braincanada.ca/about/news-updates/momentum-grants-program-awards-funding-for-bold-brain-researchPHOTO: Momentum Grant recipients (from left): Annie Ciernia, Michèle Desjardins, Mark Cembrowski, Stuart Trenholm and Mark Brandon. Brain Canada is proud to announce the five recipients of the Momentum Grants, a new program that enables researchers to build upon their previously funded Future...
-
Monitoring and Modulation of Alpha Synuclein in Microglia: Implications for Parkinson’s Disease
https://braincanada.ca/funded-grants/monitoring-and-modulation-of-alpha-synuclein-in-microglia-implications-for-parkinson-s-diseaseIn this study, we. aim to do two things: 1) monitor the distribution of a-Syn in Parkinson’s disease (PD) context to understand the factors that can cause a-Syn to build-up in certain cells of the brain, called microglia. Project Overview In this study, we. aim to do two things: 1) monitor the...
-
Montreal functional brain imaging platform
https://braincanada.ca/funded-grants/montreal-functional-brain-imaging-platformDr. Shmuel and his team are establishing a local platform which will support functional MRI (fMRI) in the alert non-human primate brain. Project Overview Dr. Shmuel and his team are establishing a local platform which will support functional MRI (fMRI) in the alert non-human primate brain. The...
-
Montreal integrated neuropsychiatric cohort: Identifying subtypes of Autism and Schizophrenia integrating genomics, endophenotypes, and cohorts of high-risk genetic variants
https://braincanada.ca/funded-grants/montreal-integrated-neuropsychiatric-cohort-identifying-subtypes-of-autism-and-schizophrenia-integrating-genomics-endophenotypes-and-cohorts-of-high-risk-genetic-variantsAutism spectrum disorders (ASD) and schizophrenia (SZ) are two psychiatric conditions that affect approximately 2% of the general population. Genetic studies have identified mutations in hundreds of genes associated with ASD and SZ. Project Overview Autism spectrum disorders (ASD) and schizophrenia...
-
Mouse brain imaging for neurodevelopmental disorders
https://braincanada.ca/funded-grants/mouse-brain-imaging-for-neurodevelopmental-disordersThe project provides state of the art mouse brain imaging to researchers in Canada working on models of neurodevelopmental disorders. Project Overview The project provides state of the art mouse brain imaging to researchers in Canada working on models of neurodevelopmental disorders. The use of...
-
MouseTRAP: The Mouse Translational Research Accelerator Platform
https://braincanada.ca/funded-grants/mousetrap-the-mouse-translational-research-accelerator-platformNeurodegenerative conditions such as Alzheimer’s and Parkinson’s disease profoundly affect aspects of cognition including memory Project Overview Neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease profoundly affect aspects of cognition including memory, attention, decision...
-
Movement Into a Mission
https://braincanada.ca/about/news-updates/movement-into-a-missionOn Sunday, October 26th, Riverdale Farm in Toronto came alive with laughter, energy, and purpose as dozens gathered for the first-ever Functional Phil Community Walk. At the heart of this fundraiser was Philippe Marsan, better known to his clients and community as Functional Phil. On Sunday,...
-
Moving discoveries from the lab towards real-world applications
https://braincanada.ca/about/news-updates/moving-discoveries-from-the-lab-towards-real-world-applicationsMRI technician prepares a participant for an MRI scan. Canada has world-class neuroscience talent, leading to high-impact discovery research in brain science. However, turning leading science into the products that will affect the course of a patient’s health requires, in part, the existence of...
-
MRI Biomarkers of Cerebral Degeneration in ALS and their Pathological Validation
https://braincanada.ca/funded-grants/mri-biomarkers-of-cerebral-degeneration-in-als-and-their-pathological-validationA biological marker, or “biomarker” for short, is a measurable indicator associated with a disease state that helps determine risk, severity and response to therapy. Project Overview A biological marker, or “biomarker” for short, is a measurable indicator associated with a disease state that helps...
-
Multi-modal neuroimaging biomarkers of Parkinson’s disease progression
https://braincanada.ca/funded-grants/multi-modal-neuroimaging-biomarkers-of-parkinson-s-disease-progressionParkinson’s disease (PD) is one of the most common neurodegenerative disorders in the world. Project Overview Parkinson’s disease (PD) is one of the most common neurodegenerative disorders in the world. PD can manifest and develop in a variety of ways for different patients, and it is currently not...